Impact of Chlorella vulgaris Supplementation on Health Outcomes in Individuals with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis Evaluated by GRADE - Top-Institutions - MDSpire

Impact of Chlorella vulgaris Supplementation on Health Outcomes in Individuals with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis Evaluated by GRADE

  • By

  • Ali Jafari

  • Helia Mardani

  • Bahare Parsi Nezhad

  • Azita Hekmatdoost

  • February 7, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Metabolic Disease
    • Nutrition

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Hepatology
    • Cardiometabolic Research
    • Clinical Nutrition

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Metabolic Disorders

  • #4

    University of California, San Diego (UCSD)
    University of California, San Diego (UCSD)

    San Diego, CA

    Key Differentiators

    • Hepatology
    • Metabolic Research
    • Nutritional Science

  • #5

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Hepatology
    • Metabolism
    • Clinical Nutrition

Original Source(s)

Impact of Chlorella vulgaris Supplementation on Health Outcomes in Individuals with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis Evaluated by GRADE

  • by Ali Jafari, Helia Mardani, Bahare Parsi Nezhad, Azita Hekmatdoost

  • February 7, 2026

Related Content

The Connection Between Periodontal Microbiota and Liver Disease Development: Insights into the Oral-Gut-Liver Axis

Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026

Clinical utility of an evolving cholestasis gene panel in 10,000 children and adults